Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion
Explore this paper's citation graph
Summary
The case of a 10-year-old boy with molecular relapse of CML following unrelated donor BMT who developed fatal grade 4 acute GVHD of the gut and liver following one antigen-mismatched donor lymphocyte infusion is reported.
- Type
- article
- Published
- 2001-09-01
- Cited by
- 4
- References
- 18
- OpenAlex
- https://openalex.org/W11607779
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30540033
Keywords
Handshake, Computer science, Cartography, Geography, Telecommunications
References
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.
- Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.
- Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.
- Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.
- Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.
- Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia.
- Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
- ANALYSIS OF THE ALLOREACTIVE T CELL REPERTOIRE IN MAN: I. DIFFERENCES IN PRECURSOR FREQUENCY FOR CYTOTOXIC T CELL RESPONSES AGAINST ALLOGENEIC MHC MOLECULES IN UNRELATED INDIVIDUALS
- Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.
- Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation
- Transplantation of Megadoses of Purified Haploidentical Stem Cells
- Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
- HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.
- Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells
- Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
- Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
- Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
- Allogeneic bone marrow and peripheral stem cell transplantation from a haplo-identical mother and CD34 positive selection for CML.
Cited by
- T-Cell Therapy: Options for Infectious Diseases
- Immunotherapy in Children: Report from the Reisensburg-Symposium October 20-22, 2004* and Recent Advances
- Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
- Emerging strategies for enhancing the homing of hematopoietic stem cells to the bone marrow after transplantation.